<SEC-DOCUMENT>0001485003-17-000097-index.html : 20171017 <SEC-HEADER>0001485003-17-000097.hdr.sgml : 20171017 <ACCEPTANCE-DATETIME>20171016215618 ACCESSION NUMBER: 0001485003-17-000097 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 8 FILED AS OF DATE: 20171017 DATE AS OF CHANGE: 20171016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-220809 FILM NUMBER: 171139742 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 </SEC-HEADER> <DOCUMENT> <TYPE>S-1/A <SEQUENCE>1 <FILENAME>ebioforms-1a12017xshortform.htm <DESCRIPTION>S-1/A <TEXT> Document 1 - file: ebioforms-1a12017xshortform.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>ebio-underwritingagreement.htm <DESCRIPTION>EXHIBIT 1.1 <TEXT> Document 2 - file: ebio-underwritingagreement.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>ex51opinionhogan.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 3 - file: ex51opinionhogan.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>ex231consentofey.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 4 - file: ex231consentofey.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>5 <FILENAME>ex232consentofpwc.htm <DESCRIPTION>EXHIBIT 23.2 <TEXT> Document 5 - file: ex232consentofpwc.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ebiologoa30.jpg <TEXT> Document 6 - file: ebiologoa30.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>ebiologoa31.jpg <TEXT> Document 7 - file: ebiologoa31.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>hllogoa02.jpg <TEXT> Document 8 - file: hllogoa02.jpg
</DOCUMENT> </SEC-DOCUMENT>